4D Molecular Therapeutics... (FDMT)
NASDAQ: FDMT
· Real-Time Price · USD
4.36
0.45 (11.51%)
At close: Jun 06, 2025, 3:59 PM
4.20
-3.56%
After-hours: Jun 06, 2025, 04:27 PM EDT
11.51% (1D)
| Bid | 3.91 |
| Market Cap | 201.74M |
| Revenue (ttm) | 9K |
| Net Income (ttm) | -176.44M |
| EPS (ttm) | -3.18 |
| PE Ratio (ttm) | -1.37 |
| Forward PE | -0.99 |
| Analyst | Buy |
| Ask | 5.3 |
| Volume | 646,000 |
| Avg. Volume (20D) | 601,184 |
| Open | 3.96 |
| Previous Close | 3.91 |
| Day's Range | 3.96 - 4.36 |
| 52-Week Range | 2.23 - 28.93 |
| Beta | 2.83 |
About FDMT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol FDMT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for FDMT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-13.91%
4D Molecular Therapeutics shares are trading lower...
Unlock content with
Pro Subscription
4 months ago
-13.77%
4D Molecular Therapeutics shares are trading lower after Leerink Partners and Morgan Stanley cut their respective price targets on the stock.
